featured
An Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett's Esophagus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus
Am. J. Gastroenterol 2024 Aug 14;[EPub Ahead of Print], SE Laun, L Kann, J Braun, S Gilbert, D Lunz, F Pierre, A Kalra, K Ma, HL Tsai, H Wang, S Jit, Y Cheng, Y Ahmed, KK Wang, CL Leggett, A Cellini, OB Ioffe, AH Zaidi, AN Omstead, B Jobe, L Korman, D Cornish, P Zellenrath, M Spaander, E Kuipers, L Perpetua, BD Greenwald, T Maddala, SJ MeltzerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.